Evogene Ltd. Operating Cycle 2011-2026 | EVGN

Annual Operating Cycle Evogene Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	30	98.8	41.9	39.7	33	36.7

All numbers in USD currency

Maximum	Minimum	Average
98.8	30	46.7

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Alnylam Pharmaceuticals ALNY	102	$ 330.34	3.6 %	$ 43.3 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Завод ДИОД DIOD	64.6	-	-	-	Russia
Фармсинтез LIFE	9.78	-	-	-	Russia
Aptorum Group Limited APM	4.89	$ 0.89	-4.33 %	$ 4.85 M	China
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Teligent, Inc. TLGT	167	-	-13.85 %	$ 16.1 M	USA
AbbVie ABBV	350	$ 206.69	-1.01 %	$ 366 B	USA
Aquestive Therapeutics AQST	223	$ 4.09	-0.97 %	$ 437 M	USA
Viela Bio, Inc. VIE	174	-	-	$ 2.91 B	USA
AbCellera Biologics ABCL	173	$ 3.39	-3.69 %	$ 1.01 B	Canada
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.22	2.37 %	$ 225 M	Israel
Ardelyx ARDX	1.05 K	$ 5.97	0.51 %	$ 1.44 B	USA
Grifols, S.A. GRFS	0.000171	$ 8.23	-0.12 %	$ 6.83 B	Spain
Akebia Therapeutics AKBA	210	$ 1.32	-4.35 %	$ 339 M	USA